Characterising nitric oxide-mediated metabolic benefits of low-dose ultraviolet radiation in the mouse: a focus on brown adipose tissue.
Brown adipose tissue
Circadian rhythm
Hepatic steatosis
High-fat diet
Metabolic dysfunction
Mice
Nitric oxide
Ultraviolet radiation
Uncoupling protein-1
Whitening
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
21
03
2019
accepted:
29
08
2019
pubmed:
13
11
2019
medline:
28
11
2020
entrez:
13
11
2019
Statut:
ppublish
Résumé
Exposure to sunlight has the potential to suppress metabolic dysfunction and obesity. We previously demonstrated that regular exposure to low-doses of ultraviolet radiation (UVR) reduced weight gain and signs of diabetes in male mice fed a high-fat diet, in part via release of nitric oxide from skin. Here, we explore further mechanistic pathways through which low-dose UVR exerts these beneficial effects. We fed mice with a luciferase-tagged Ucp1 gene (which encodes uncoupling protein-1 [UCP-1]), referred to here as the Ucp1 luciferase transgenic mouse ('Thermomouse') a high-fat diet and examined the effects of repeated exposure to low-dose UVR on weight gain and development of metabolic dysfunction as well as UCP-1-dependent thermogenesis in interscapular brown adipose tissue (iBAT). Repeated exposure to low-dose UVR suppressed the development of glucose intolerance and hepatic lipid accumulation via dermal release of nitric oxide while also reducing circulating IL-6 (compared with mice fed a high-fat diet only). Dietary nitrate supplementation did not mimic the effects of low-dose UVR. A single low dose of UVR increased UCP-1 expression (by more than twofold) in iBAT of mice fed a low-fat diet, 24 h after exposure. However, in mice fed a high-fat diet, there was no effect of UVR on UCP-1 expression in iBAT (compared with mock-treated mice) when measured at regular intervals over 12 weeks. More extensive circadian studies did not identify any substantial shifts in UCP-1 expression in mice exposed to low-dose UVR, although skin temperature at the interscapular site was reduced in UVR-exposed mice. The appearance of cells with a white adipocyte phenotype ('whitening') in iBAT induced by consuming the high-fat diet was suppressed by exposure to low-dose UVR in a nitric oxide-dependent fashion. Significant shifts in the expression of important core gene regulators of BAT function (Dio2, increased more than twofold), fatty acid transport (increased Fatp2 [also known as Slc27a2]), lipolysis (decreased Atgl [also known as Pnpla2]), lipogenesis (decreased Fasn) and inflammation (decreased Tnf), and proportions of macrophages (increased twofold) were observed in iBAT of mice exposed to low-dose UVR. These effects were independent of nitric oxide released from skin. Our results suggest that non-burning (low-dose) UVR suppresses the BAT 'whitening', steatotic and pro-diabetic effects of consuming a high-fat diet through skin release of nitric oxide, with some metabolic and immune pathways in iBAT regulated by UVR independently of nitric oxide.
Identifiants
pubmed: 31713010
doi: 10.1007/s00125-019-05022-5
pii: 10.1007/s00125-019-05022-5
doi:
Substances chimiques
Blood Glucose
0
Uncoupling Protein 1
0
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-193Références
Int J Obes (Lond). 2013 Jun;37(6):853-60
pubmed: 22964790
Obesity (Silver Spring). 2012 Jul;20(7):1527-9
pubmed: 22447290
Cell Rep. 2014 Dec 11;9(5):1584-1593
pubmed: 25466254
Cell Rep. 2017 Sep 12;20(11):2678-2692
pubmed: 28903047
J Invest Dermatol. 2009 Apr;129(4):834-42
pubmed: 18818674
Antioxid Redox Signal. 2012 Aug 1;17(3):422-32
pubmed: 22133018
J Invest Dermatol. 2014 Jul;134(7):1839-1846
pubmed: 24445737
Cell Metab. 2009 Feb;9(2):203-9
pubmed: 19187776
Cell Metab. 2016 Apr 12;23(4):602-9
pubmed: 26972823
Photochem Photobiol Sci. 2017 Mar 16;16(3):362-373
pubmed: 28009891
J Lipid Res. 2018 May;59(5):784-794
pubmed: 29599420
Diabetes. 2015 Feb;64(2):471-484
pubmed: 25249574
Biochimie. 2017 Mar;134:28-34
pubmed: 27984203
J Endocrinol. 2017 Apr;233(1):81-92
pubmed: 28154004
Cell Rep. 2018 Mar 27;22(13):3521-3533
pubmed: 29590620
J Clin Invest. 2013 Jan;123(1):215-23
pubmed: 23221344
J Exp Biol. 2018 Mar 7;221(Pt Suppl 1):
pubmed: 29514884
Front Physiol. 2017 Jul 31;8:520
pubmed: 28824441
PLoS One. 2015 Mar 13;10(3):e0119784
pubmed: 25768847
BMC Res Notes. 2019 Feb 11;12(1):78
pubmed: 30744663
Diabetes. 2014 Nov;63(11):3759-69
pubmed: 25342734
J Immunol. 2017 Apr 1;198(7):2927-2934
pubmed: 28193830
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12814-9
pubmed: 11606734
Acta Physiol (Oxf). 2014 Mar;210(3):498-507
pubmed: 24716231
J Dermatol Sci. 2007 Sep;47(3):241-3
pubmed: 17572071
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E729-E740
pubmed: 30807213
Essays Biochem. 2010;47:53-67
pubmed: 20533900
Am J Physiol. 1989 Jun;256(6 Pt 1):E773-9
pubmed: 2500023
Neurosci Lett. 2019 Mar 23;696:225-232
pubmed: 30586638
Int J Mol Sci. 2012 Dec 21;14(1):191-204
pubmed: 23344028
PLoS One. 2017 Mar 13;12(3):e0173661
pubmed: 28288167
PLoS One. 2012;7(9):e46006
pubmed: 23049920
J Virol. 2019 Jul 17;93(15):
pubmed: 31092580
FASEB J. 2018 Oct;32(10):5640-5646
pubmed: 29715048
Nat Rev Endocrinol. 2018 Feb;14(2):77-87
pubmed: 29052591